The global uterine fibroid
treatment market is witnessing considerable growth due to increasing
female geriatric population, increasing healthcare expenditure, increasing
prevalence of obesity, launch of technologically advanced fibroid treatment products
and growing popularity of minimally invasive treatments. Moreover, growing
prevalence of hormonal disorders or hormonal imbalance leading to fibroid
formation is supporting the growth of the market. The increasing adoption of uterine
fibroid treatment across the globe, owing to increasing incidence of cancer is also
driving the growth of the market.
Request for Report Sample at: https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market/report-sample
The rapid growth in emerging economies and technological advancement
in fibroid treatment with presence of minimally invasive treatment options is
expected to create opportunities for the manufacturers of uterine fibroid treatment
products. However, high cost of uterine fibroid treatment and presence of
alternative treatment options are the key factors hampering the growth of the
global market.
The increasing female aging population is propelling the growth of
the global uterine fibroid treatment market. As reported by UN DESA (United
Nation Department of Economic and Social Affairs) in the year 2013, the elder
population is predominantly female. As women tend to live longer than men,
while older women have outnumbered older men almost everywhere in the world. It
further reported that in the year 2013, globally there were 85 men per 100
women in the age group 60 years or plus; and 61 men per 100 women in the age
group 80 years or plus. The elderly population is more susceptible to gynecological
problems, such as abnormal uterine bleeding, hormonal imbalance, and irregular
menstrual cycle as compared to adults, which is fueling the demand of the
global fibroid treatment market.
Explore Report at: https://www.psmarketresearch.com/market-analysis/uterine-fibroid-treatment-market
The key players operating in the global market are Boston
Scientific Corporation, CooperSurgical, Inc., Karl Storz, Halt Medical, Inc., Merit
Medical Systems, LiNA Medical USA, Olympus Corporation, and Richard Wolf GmbH.
No comments:
Post a Comment